Empagliflozin protects mice against diet-induced obesity, insulin resistance and hepatic steatosis.
Radlinger B, Ress C, Folie S, Salzmann K, Lechuga A, Weiss B, Salvenmoser W, Graber M, Hirsch J, Holfeld J, Kremser C, Moser P, Staudacher G, Jelenik T, Roden M, Tilg H, Kaser S.
Radlinger B, et al. Among authors: ress c.
Diabetologia. 2023 Apr;66(4):754-767. doi: 10.1007/s00125-022-05851-x. Epub 2022 Dec 16.
Diabetologia. 2023.
PMID: 36525084
Free PMC article.